Literature DB >> 34161495

Microbiological profile of leg ulcer infections: review study.

Taysa de Fátima Garcia1, Eline Lima Borges1, Thaisa Oliveira de Castro Junho1, Josimare Aparecida Otoni Spira1.   

Abstract

OBJECTIVES: to analyze the microbiological profile of leg ulcers of patients treated at outpatient clinics and hospitals regarding the type of microorganism, microbiological selection of antibiotics, and techniques for the collection of culture material.
METHODS: literature review performed on LILACS, IBECS, MEDLINE, and CINAHL databases, resulting in a descriptive analysis of 27 studies.
RESULTS: 35.7% of the studies occurred in an outpatient care scenario; and 64.2% in hospitals. There was a predominance of swab (100%) in outpatient care and biopsy (55.5%) in the hospital. Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus were more common at both levels of assistance. Methicillin-resistant Staphylococcus aureus was isolated in both.
CONCLUSIONS: the microbiological profile of infections was similar, with the presence of resistant bacteria in both environments. This fact causes concern and raises the need for research to elucidate it. The studies did not compare the effectiveness between biopsy and swab.

Entities:  

Year:  2021        PMID: 34161495     DOI: 10.1590/0034-7167-2019-0763

Source DB:  PubMed          Journal:  Rev Bras Enferm        ISSN: 0034-7167


  2 in total

1.  Biofilm model on mice skin wounds.

Authors:  Eline Lima Borges; Gilmara Lopes Amorim; Marina Barcelos de Miranda; Flaviano Dos Santos Martins; Antônio Carlos Martins Guedes; Kinulpe Honorato Sampaio; Josimare Aparecida Otoni Spira; Lucíola da Silva Barcelos
Journal:  Acta Cir Bras       Date:  2022-06-01       Impact factor: 1.564

2.  Microbiological Status of Venous Leg Ulcers and Its Predictors: A Single-Center Cross-Sectional Study.

Authors:  Justyna Cwajda-Białasik; Paulina Mościcka; Arkadiusz Jawień; Maria Teresa Szewczyk
Journal:  Int J Environ Res Public Health       Date:  2021-12-08       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.